Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05905705

Disruptions of Brain Networks and Sleep by Electroconvulsive Therapy

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Washington University School of Medicine · Academic / Other
Sex
All
Age
21 Years – 65 Years
Healthy volunteers

Summary

Electroconvulsive therapy (ECT) alleviates treatment-resistant depression (TRD) through repeated generalized seizures. The goal of this study is to evaluate how ECT impacts sleep-wake regulation and efficiency of information transfer in functional networks in different states of arousal.

Detailed description

Graph-based network analyses of electroencephalographic (EEG) signals allow characterization of functional networks. The robustness of local networks to disruption is quantified as local efficiency (Elocal), while network integration is quantified as global information transfer (Eglobal). Aim 1: Assess relationships between sleep slow-wave activity (SWA) and awake Elocal over the course of ECT. Aim 2: Quantify relationships between depression severity and awake Elocal over the course of ECT.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTElectroencephalography (EEG)High-density EEG will be acquired during resting wakefulness before each ECT session.
DIAGNOSTIC_TESTQuantitative Measurements of Sleep MicrostructureOvernight sleep EEG will be recorded one day before each ECT session using the DREEM device. The DREEM device allows continuous recording of multichannel EEG.

Timeline

Start date
2023-03-07
Primary completion
2027-07-31
Completion
2027-07-31
First posted
2023-06-15
Last updated
2026-03-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05905705. Inclusion in this directory is not an endorsement.